US EditionHanmi Pharmaceutical's 'Gugutams' to be Launched in Mexico as 'Aditams', Marking the Start of Full-Scale Latin America Expansion
- Hanmi Pharmaceutical launched Aditams, containing Gugutams, in Mexico in February 2025 under an export agreement.
- Hanmi Pharmaceutical signed an export agreement with Laboratorios Silanes in October 2020 to facilitate the launch.
- Gugutams combines tamsulosin and tadalafil, treating Obstructive Prostatic Growth and erectile dysfunction .
- Park Jae-hyun, Hanmi Pharmaceutical's CEO, stated Aditams is expected to present a new treatment paradigm.
- Hanmi Pharmaceutical aims to solidify its presence in Latin America through its collaboration with Laboratorios Silanes.
Insights by Ground AI
Does this summary seem wrong?
32 Articles
32 Articles
All
Left
4
Center
7
Right
4
Altavista Journal+31 Reposted by 31 other sources
Hanmi Pharmaceutical's 'Gugutams' to be Launched in Mexico as 'Aditams', Marking the Start of Full-Scale Latin America Expansion
Hanmi Pharm Begins Local Sales of Urological Product 'Aditams' in Mexico with Partner 'Laboratorios Silanes'
·Altavista, United States
Read Full ArticleCoverage Details
Total News Sources32
Leaning Left4Leaning Right4Center7Last UpdatedBias Distribution47% Center
Bias Distribution
- 47% of the sources are Center
47% Center
L 27%
C 47%
R 27%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
